日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression.

在 RUNX1 和 SRSF2 突变背景下,杂合 CEBPA 突变破坏了 bZIP 结构域,导致 MDS 疾病进展

Almaghrabi Ruba, Alyahyawi Yara, Keane Peter, Mian Syed A, Habel Khadidja, Atkinson Amelia, Ward Carl, Bayley Rachel, Sargas Claudia, Menendez Pablo, Murphy George J, Sobahy Turki, Baghdadi Mohammed A, Flemban Arwa F, Kabrah Saeed M, Torres-Ruiz Raul, Papapetrou Eirini P, Akerman Ildem, Raghavan Manoj, Barragan Eva, Bonnet Dominique, Bonifer Constanze, Garcia Paloma

SETD1A-dependent EME1 transcription drives PARPi sensitivity in HR deficient tumour cells.

SETD1A 依赖的 EME1 转录驱动 HR 缺陷肿瘤细胞对 PARPi 的敏感性

Sweatman Ellie, Bayley Rachel, Selemane Richad, Higgs Martin R

New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers

关于HR缺陷型癌症中表观遗传修饰和PARP抑制剂耐药性的新观点

Bayley, Rachel; Sweatman, Ellie; Higgs, Martin R

On your marks, get SET(D1A): the race to protect stalled replication forks

各就各位,开始 SET(D1A):保护停滞复制分支的竞赛

Begum, Shabana; Goula, Amalia; Bayley, Rachel; Higgs, Martin R

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

MYBL2 mRNA表达作为骨髓增生异常综合征基因毒性治疗疗效的潜在生物标志物

Bayley, Rachel; Blakemore, Daniel; García, Paloma

Differential expression of CD148 on leukocyte subsets in inflammatory arthritis

炎症性关节炎中白细胞亚群上CD148的差异表达

Dave, Richa K; Naylor, Amy J; Young, Stephen P; Bayley, Rachel; Hardie, Debbie L; Haworth, Oliver; Rider, David A; Cook, Andrew D; Buckley, Christopher D; Kellie, Stuart